Cure three out of four patients by 2030

Cancer Core Europes’ Chief Scientific Officer, Fabien Calvo, was interviewed by Mathias Germain from the French Magazine "la recherche" about how Cancer Core Europe will drive the cure rate of cancer to 75%

A cell-by-cell analysis of tumours, drugs that target their genetic abnormalities... These advances and the implementation of more effective clinical trials give great hope for better cancer treatment. Fabien Calvo, oncologist and Scientific Director of Cancer Core Europe, explains the current advances and those promoted by artificial intelligence.

Original article in French

NewsCancerCore Europe